BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21070848)

  • 1. NOS-mediated morphological and molecular modifications in rats infused with Aβ (1-40), as a model of Alzheimer's disease, in response to a new lipophilic molecular combination codrug-1.
    Zara S; Di Stefano A; Nasuti C; Rapino M; Patruno A; Pesce M; Sozio P; Cerasa LS; Cataldi A
    Exp Gerontol; 2011 Apr; 46(4):273-81. PubMed ID: 21070848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ibuprofen and lipoic acid codrug 1 control Alzheimer's disease progression by down-regulating protein kinase C ε-mediated metalloproteinase 2 and 9 levels in β-amyloid infused Alzheimer's disease rat model.
    Zara S; Rapino M; Sozio P; Di Stefano A; Nasuti C; Cataldi A
    Brain Res; 2011 Sep; 1412():79-87. PubMed ID: 21820649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease.
    Pinnen F; Sozio P; Cacciatore I; Cornacchia C; Mollica A; Iannitelli A; D'Aurizio E; Cataldi A; Zara S; Nasuti C; Di Stefano A
    Arch Pharm (Weinheim); 2011 Mar; 344(3):139-48. PubMed ID: 21384412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity.
    Sozio P; D'Aurizio E; Iannitelli A; Cataldi A; Zara S; Cantalamessa F; Nasuti C; Di Stefano A
    Arch Pharm (Weinheim); 2010 Mar; 343(3):133-42. PubMed ID: 20186865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
    Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
    Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibuprofen and lipoic acid diamide as co-drug with neuroprotective activity: pharmacological properties and effects in beta-amyloid (1-40) infused Alzheimer's disease rat model.
    Di Stefano A; Sozio P; Cerasa LS; Iannitelli A; Cataldi A; Zara S; Giorgioni G; Nasuti C
    Int J Immunopathol Pharmacol; 2010; 23(2):589-99. PubMed ID: 20646354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
    Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-beta (25-35) increases activity of neuronal NO-synthase in rat brain.
    Stepanichev MY; Onufriev MV; Yakovlev AA; Khrenov AI; Peregud DI; Vorontsova ON; Lazareva NA; Gulyaeva NV
    Neurochem Int; 2008 May; 52(6):1114-24. PubMed ID: 18207612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease.
    Han M; Liu Y; Tan Q; Zhang B; Wang W; Liu J; Zhang XJ; Wang YY; Zhang JM
    Eur J Pharmacol; 2011 Apr; 657(1-3):104-10. PubMed ID: 21316359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of the aminoestrogen prolame against impairment of learning and memory skills in rats injected with amyloid-β-25-35 into the hippocampus.
    Limón D; Díaz A; Hernandez M; Fernandez-G JM; Torres-Martínez AC; Pérez-Severiano F; Rendón-Huerta EP; Montaño LF; Guevara J
    Eur J Pharmacol; 2012 Jun; 685(1-3):74-80. PubMed ID: 22542664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ibuprofen and lipoic acid conjugate neuroprotective activity is mediated by Ngb/Akt intracellular signaling pathway in Alzheimer's disease rat model.
    Zara S; De Colli M; Rapino M; Pacella S; Nasuti C; Sozio P; Di Stefano A; Cataldi A
    Gerontology; 2013; 59(3):250-60. PubMed ID: 23428737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red mold rice ameliorates impairment of memory and learning ability in intracerebroventricular amyloid beta-infused rat by repressing amyloid beta accumulation.
    Lee CL; Kuo TF; Wang JJ; Pan TM
    J Neurosci Res; 2007 Nov; 85(14):3171-82. PubMed ID: 17663476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
    Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
    J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mefenamic acid shows neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer's disease models.
    Joo Y; Kim HS; Woo RS; Park CH; Shin KY; Lee JP; Chang KA; Kim S; Suh YH
    Mol Pharmacol; 2006 Jan; 69(1):76-84. PubMed ID: 16223958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.
    Imbimbo BP; Del Giudice E; Colavito D; D'Arrigo A; Dalle Carbonare M; Villetti G; Facchinetti F; Volta R; Pietrini V; Baroc MF; Serneels L; De Strooper B; Leon A
    J Pharmacol Exp Ther; 2007 Dec; 323(3):822-30. PubMed ID: 17895400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of memantine on soluble Alphabeta(25-35)-induced changes in peptidergic and glial cells in Alzheimer's disease model rat brain regions.
    Arif M; Chikuma T; Ahmed MM; Nakazato M; Smith MA; Kato T
    Neuroscience; 2009 Dec; 164(3):1199-209. PubMed ID: 19733635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-aggregated Aβ(25-35) alters arginine metabolism in the rat hippocampus and prefrontal cortex.
    Liu P; Jing Y; Collie ND; Campbell SA; Zhang H
    Neuroscience; 2011 Oct; 193():269-82. PubMed ID: 21807072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of intrahippocampal beta amyloid (1-42) peptide injection on oxidant and antioxidant status in rat brain.
    Cetin F; Dincer S
    Ann N Y Acad Sci; 2007 Apr; 1100():510-7. PubMed ID: 17460216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells.
    Blasko I; Apochal A; Boeck G; Hartmann T; Grubeck-Loebenstein B; Ransmayr G
    Neurobiol Dis; 2001 Dec; 8(6):1094-101. PubMed ID: 11741404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferulic acid ethyl ester protects neurons against amyloid beta- peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity.
    Sultana R; Ravagna A; Mohmmad-Abdul H; Calabrese V; Butterfield DA
    J Neurochem; 2005 Feb; 92(4):749-58. PubMed ID: 15686476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.